Provocative Tests for HFpEF
TEST-PEF
Provocative Tests for Diagnosing and Phenotyping Heart Failure With Preserved Ejection Fraction
1 other identifier
observational
500
1 country
1
Brief Summary
Diagnosing heart failure with preserved ejection fraction (HFpEF) in patients complaining exertional breathlessness can be challenging: diagnostic algorithms and scores have low sensitivity, and ageing-associated comorbidities can complicate the interpretation of symptoms. Thus, exercise right heart catheterization (RHC) or invasive cardiopulmonary exercise test (iCPET) have been advocated as gold-standard methods for HFpEF diagnosis. However, exercise RHC and iCPET are still not widely standardized methods, with results mainly coming from US cohorts (that may differ from Italian cohorts), and other provocative tests (e.g. non-invasive CPET, passive leg raising) may offer complementary diagnostic information.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2023
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 10, 2023
CompletedFirst Submitted
Initial submission to the registry
March 7, 2024
CompletedFirst Posted
Study publicly available on registry
March 13, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
March 1, 2028
August 3, 2025
August 1, 2025
5 years
March 7, 2024
August 1, 2025
Conditions
Outcome Measures
Primary Outcomes (3)
Mortality
Incidence of mortality
5 years
Hospitalization for heart failure
Incidence of hospitalization for heart failure
5 years
Atrial fibrillation
Incidence of atrial fibrillation
5 years
Interventions
exercise test
Eligibility Criteria
Consecutive patients referred to the Dyspnea and Pulmonary Hypertension Center for suspicion of HF, PH or unexplained dyspnea
You may qualify if:
- dyspnea
You may not qualify if:
- known HFpEF
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ospedale San Luca IRCCS Istituto Auxologico Italiano
Milan, 20149, Italy
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 5 Years
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 7, 2024
First Posted
March 13, 2024
Study Start
March 10, 2023
Primary Completion (Estimated)
March 1, 2028
Study Completion (Estimated)
March 1, 2028
Last Updated
August 3, 2025
Record last verified: 2025-08